Wise named Cline Davis & Mann CEO

Share this article:
Ed Wise has been named CEO of Cline Davis & Mann (CDM), while Carol DiSanto will succeed Wise as president. The executive level moves, first announced today, follow the November retirement announcement made by CDM COO Jack Slonaker to pursue personal interests. Wise joined CDM in 1984 and was named president in 2001, helping diversify the Omnicom-owned agency's client roster by adding clients including Amgen, Novartis, NovoNordisk. DiSanto, a 15-year CDM veteran, served most recently as CDM director of client services, working on brands including the Pfizer blockbusters Lipitor and Viagra and Amgen’s Aranesp.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.